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INTRODUCTION 
Thyrotoxicosis is a syndrome which is caused by excessive secretion of 
thyroid hormone. 
Goitre is derived from the Latin word Guttur  which means throat. 
The thyroid gland is first documented by Italians of the renaissance 
period. 
The term Thyroid (Greek Thyreoeides, Shield Shaped) is attributed to 
Thomas Wharton. 
Bernard courtois discovered iodine in the ash of burnt seaweed.The first 
accounts of thyroid surgery dates back to Roger Frugardi in 1170. 
The most notable thyroid surgeons were Emil Theodor Kocher (1841 – 
1917 ) & Theodor Billroth ( 1829 – 1894 ). 
Emil Theodor Kocher of Berne  is regarded by many as Father Of 
Thyroid Surgery . 
In 1909, Kocher  Received The Nobel Prize for medicine in recognition 
“for his works on physiology , pathology , & surgery of thyroid gland  ״ 
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AIM OF STUDY 
1. Review the data regarding the prevalence of  Thyrotoxicosis & its 
association with standard  variables. 
2.  Discuss the  various clinical presentations of  thyrotoxicosis. 
3. Discussion of etiopathogenesis in thyrotoxicosis 
4. Discussion of various treatment modalities 
5. Evaluate a cost effective treatment for a country like ours 
6. Discuss the complications of treatment & follow up 
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ANATOMY OF THYROID 
The  thyroid gland occupies an important position in the centre of the 
visceral compartment of the neck, lying astride the trachea, just above the 
thoracic inlet. It normally weighs  about 15 – 20 gm. 
The gland consists of two symmetrical lobes , united in front of 2nd ,   
3rd, 4 th tracheal rings by an isthmus of the gland. The extent of thyroid gland is 
from thyroid cartilage to the 5th or 6th tracheal ring  or  from C3 to T1. 
The lobes are approximately 4 cm long , 2 cm wide , 20 to 40 mm thick , 
with the isthmus 2 to 6 mm thick. Each lobe is pear shaped , consisting of a 
narrow upper pole & a broader lower pole. The thyroid gland is covered by 
fascia & strap muscles , & more laterally  it is tucked under the diverging 
anterior borders of the sternomastoid muscles & adjacent to the lobes on the 
medial side , is the carotid sheath. 
PYRAMIDAL LOBE 
It  is present in 80 % of individuals  , usually to the left of midline, 
extending upwards from the isthmus along the anterior surface of the thyroid 
cartilage. It is a remnant of thyroglossal cyst.      
The gland moves upwards on deglutition , because of its facial 
attachments. The normal gland is impalpable though it can palpated in thin 
individuals. 
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FACIAL COVERINGS 
The strap muscles are ensheathed by investing layer of deep cervical 
fascia. These muscles are applied to the anterior surface of the gland  & 
separated  by a loose condensation of fascia derived from the pretracheal fascia. 
This false capsule covers the gland which is enclosed by its true capsule with 
its rich blood supply.  
The pretracheal fascia is attached above to the thyroid cartilage & 
cricoid cartilage & this suspension of thyroid from the larynx accounts for its 
movement on deglutition. 
During surgery, the investing layer of deep cervical fascia is opened in 
the midline vertically which is relatively avascular. The space between the 
gland & strap muscle is entered & the strap muscles are retracted. 
The strap muscles are supplied from the cervical roots 1,2,& 3 via the 
Ansa Cervicalis. These enter the muscle at its lateral border & on the deeper 
surface & the muscles can be divided transversely to facilitate access to the 
gland , provided they are resutured , there does not appear to be any functional 
impairment. 
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BLOOD SUPPLY: 
ARTERIAL SUPPLY: 
                      ARTERY                      ORIGIN 
¾ Superior thyroid artery  → External Carotid  artery. 
¾ Inferior thyroid artery   → thyrocervical  trunk from 1st part   
                                                       of subclavian artery 
¾ Thyroidea ima artery  →    arch of aorta  or innominate artery 
 
The superior thyroid artery descends down from its origin & runs to the 
superior pole . And as it reaches the gland it divides into anterior & posterior 
branches. 
The inferior thyroid artery passes behind the carotid sheath & runs 
transversely across the space between the thyroid & carotid sheath to enter the 
deeper surface of the gland as separate branches. The recurrent laryngeal nerve 
usually lies posterior to these branches or sometimes inbetween  or anterior to 
them. 
VENOUS DRAINAGE: 
A rich venous plexus forms underneath the capsule & drains 
correspondingly as follows: 
VEIN                     →       DRAINS 
¾ Superior thyroid vein → internal jugular vein 
¾ Middle thyroid vein   → internal jugular vein 
¾ Inferior thyroid vein → brachio cephalic vein 
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The middle thyroid vein runs a short course, passes from middle lobe 
directly to internal jugular vein. 
From the isthmus & lower pole the inferior thyroid vein forms a plexus 
that lies in the pre tracheal fascia & drains into the brachio cephalic vein. 
LYMPHATIC DRAINAGE: 
The lymphatic drainage of the thyroid is principally to the internal 
jugular nodes. The superior pole & the medial isthmus drain to the superior 
group, and the inferior drain the lower gland & empty into pretracheal  &  
paratracheal nodes. 
NERVE SUPPLY: 
¾ SYMPATHETIC → Superior & middle  cervical  sympathetic ganglia 
¾ PARASYMPATHETIC→ Laryngeal br. Of Vagus  
• Superior laryngeal nerve (external & internal) 
• Recurrent laryngeal nerve. 
The sympathetic nerves travel along the blood vessels to the thyroid & 
are vasomotor in action.The thyroid gland’s relation to the recurrent laryngeal 
nerve & external laryngeal nerve is of major significance. Identification of 
these nerves rather than avoiding should be a standard practice for the surgeon. 
The recurrent nerve supplies the intrinsic muscles of larynx except the 
cricothyroid which is supplied by the external laryngeal nerve. Cricothyroid is 
a tensor of vocal cord & affects the pitch of the voice. 
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Recurrent laryngeal nerve:  
Right: On the right the recurrent nerve originates from the vagus where 
it crosses the 1st part of the subclavian artery .The nerve then loops the 
subclavian artery & ascends slightly obliquely to enter the larynx at the level of 
cricoid cartilage & posterior to the cricothyroid muscle.  
Left : The nerve originates from the vagus as it crosses the aortic arch & 
loops posteriorly around the ligamentum arteriosus before it ascends medially 
in the tracheo oesophageal groove to enter the larynx opposite the contralateral 
nerve. 
 Nerve in tracheo oesophageal groove  
 right → 64 %  
 left  → 77 %.   
 Nerve in relation to the inferior thyroid artery 
 Posterior to artery → right →  53 %  
 →left     →  69 %.  
          In others the nerve is either anterior or in between the branches. The 
most meticulous step  during thyroid surgery is during the dissection where the 
recurrent nerve passes through the Berry’s ligament. It is here the nerve is in 
close proximity to the thyroid gland , tethered down by the  ligament , & it is 
here the nerve is most commonly injured. 
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Non recurrent recurrent laryngeal nerve: 
¾ Exclusively on the right  
¾ 1% of individuals 
¾ associated with anomaly of subclavian artery 
¾ nerve runs directly to larynx after its origin from  vagus. 
EXTERNAL LARYNGEAL NERVE :  
The nerve runs on the lateral surface of the inferior constrictor muscle to 
innervate the cricothyroid muscle & lies in close proximity to the superior pole 
vessels.  
Nerve supplies the cricothyroid muscle which tensor of vocal cord 
which affects the pitch of the voice.In 80 % of individuals the nerve can be 
found over the cricothyroid muscle. 
HISTOLOGY OF THE THYROID GLAND: 
Microscopically the gland is divided into lobules that contain 20 to 40 
follicles.These are roughly 3 × 106  follicles in each gland. Follicles are 
spherical & averages 30µm in size. Follicle is lined by cuboidal epithelium& 
contains a central core of colloid secreted from the epithelial cels. 
When the gland activity is more as in the case of hyperthyroidism ,the 
follicular epithelium is high & columnar & the colloid is reduced.  
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Sparsely intermingled between the follicular cells & also within the 
interfollicular spaces are the PARAFOLLICULAR or C CELLS  which secrete 
calcitonin. 
The C cells are mostly concentrated in the superior pole , reflecting their 
origin as neuroectodermal cells derived from the Ultimobranchial bodies , & 
are a part of APUD series described by Pearse. 
EMBRYOLOGY OF THYROID: 
The thyroid develops as an endodermal tubular structure from the 
posterior aspect of fetal tongue , and grows downwards in front of the 
developing hyoid & larynx , bifurcating & fusing with growth elements from 
the 4th   branchial pouch . The  stem of the down growth forms the thyroglossal 
duct whose upper end remains as foramen caecum  of the tongue , the lower 
end forms the pyramidal lobe . Thyroglossal duct usually atrophies but may 
remain in whole or in part & produce abnormalities. 
It is joined laterally by a pair of components originating from the 
Ultimobranchial bodies of the 4th & 5th pharyngeal pouches. These lateral 
components supply the C cells of the thyroid which secrete calcitonin. 
The superior parathyroids develop from the 4th pharyngeal pouch & it is 
in close relationship to the superior aspect of thyroid. 
The inferior parathyroids develop from the 3rd pharyngeal pouch & is 
developmentally related to thymus. 
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PHYSIOLOGY 
IODINE METABOLISM: 
The average daily requirement of iodine is 0.1 mg. Iodine  in the 
stomach & duodenum is converted to iodide & is absorbed . It is actively 
transported to thyroid by an ATP dependent process. The normal serum to 
thyroid Iodine  ratio is about 1׃5 . But can be as high as 1׃ 500. Thyroid 
hormones T 4 & T 3 are bound to thyroglobulin within the colloid.  
Synthesis is as follows : 
¾ Trapping of organic iodide 
¾ Oxidation of iodide to iodine 
¾ Binding of iodine with tyrosine to form iodotyronine  
¾ Coupling of monoiodotyrosine (MIT) and diiodotyrosine (DIT) to form 
T3 , T4 ,Rt3. 
All the above steps in thyroid synthesis is accelerated by TSH acting 
through a specific membrane receptor via the Cyclic amp second messenger 
system. 
The coupling & oxidation of iodide are catalysed by peroxidase enzyme 
which is inhibited by propylthiouracil & carbimazole.  
The hormones so synthesized are stored in colloid within the 
thyroglobulin. When the hormones are required the complex is reabsorbed into 
the epithelium by endocytosis & broken down by the lysosomes. This results in 
the formation of T4,T3,Rt3, MIT,DIT. 
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The MIT & DIT are deiodinated & Iodine is reused. The T3 & T4 enter 
the circulation & transported bound to Thyroxine binding  globulin  (TBG), 
Thyroxine Binding Pre Albumin (TBPA ) & albumin . 
99.98 % of thyroid hormones are bound to protein & only 0.02 % is free 
& active physiological form .  r T3 is biologically inert. The circulating level of 
T4 to T3 is 10׃ 1 to 20׃ 1. T3 is more potent , less lightly bound to protein , 3 – 
4 times more active than T4. About 75 % of T3 is produced from peripheral 
conversion of T4 to T3 which is inhibited by β blockers. 
HYPOTHALAMO PITUITARY THYROID AXIS: 
Synthesis & liberation of thyroid hormones is controlled by Thyroid 
stimulating hormone ( thyrotropin) TSH  secreted by basophil cells of  anterior 
pituitary. The TSH is in turn controlled by thyrotropin releasing hormone 
(TRH) secreted by the hypothalamus. 
MOLECULAR BASIS OF THYROID HORMONE ACTION: 
The thyroid hormones are transported across the plasma membrane of 
the tissues by ATP dependent transport system . 
Uptake by the tissue is rate limited by the amount of free hormone 
avilableat the tissur level . 
At the cellular level T3 is the active hormone , & its activity is mediated 
through T3 receptors located in the cell nucleus . 
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OUTLINE OF THYROTOXICOSIS 
Syndrome that results when excessive levels of thyroid hormones are 
secreted into circulation. The term thyrotoxicosis is retained because symptoms 
due to raised level of  hormone is not responsible for all the manifestations of 
the disease. 
CLASSIFICATION 
I) BASED ON ETIOLOGY: 
A)Primary Alteration Within The Thyroid: 
Graves’ disease 
Toxic MNG 
Toxic adenoma 
 B)CNS Disorders – Increased Tsh Secretion 
II)BASED ON HORMONE SECRETION 
With Increased Thyroid Hormone   
Secretion       
            Graves’ Disease  - Primary Thyrotoxicosis 
             Toxic Nodular Goitre 
             Toxic Thyroid Adenoma 
             Jod – Basedow Hyperthyroidism 
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Without Increased Thyroid    
Hormone     Secretion 
            Subacute   Thyroiditis 
            Factitious  Hyperthyroidism 
            Functioning  Metastatic  Ca  Thyroid 
            Struma  Ovarii (ovarian teratoma containing  thyroid)  
            Molar Pregnancy – increased beta HCG 
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ETIOPATHOGENESIS GRAVES’   DISEASE 
( DIFFUSE TOXIC GOITRE ) 
Originally described by Caleb Pary – Welsch Physician – 1825. Named after 
Robert Graves  - Ireland – 1835. 
It is the most common form of thyrotoxicosis. 
Affects young adults (20 – 40 yrs) . 
6 times more common in females. 
EXTRA THYROIDAL MANIFESTATIONS :  
Ophthalmopathy, Pretibial Myxedema,Vitiligo, Thyroid Acropathy is 
common. 
AETIOLOGY : 
It is an autoimmune disorder. The disease  was  originally thought to  be  
due  to  LATS ( LONG ACTING THYROID STIMULATING ANTIBODY) 
described by Adams & Parves in 1956.  
           It is recently demonstrated that the disease is due to wide range of 
antibodies termed as  TRAb (THYROID RECEPTOR ANTIBODIES).Thyroid 
stimulating antibodies or Ig are directed at TSH receptor on follicular cells. 
TSI or TSAb -thyroid stimulating Ab or Ig  stimulate TSH receptors on 
follicular cells. 
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TSII  or TBIA- TSH binding inhibiting Ig or Ab . All these Ab are 
grouped as TRAb.   
          What iniates the Graves’  &  Ab production is unclear. Various theories:   
1) Defect in the T suppressor cell . 
2) Immune response is launched to altered antigens on the follicular 
cell surface. 
3) Genetic factors- Twins have increased chance. Probably due to 
increased frequency of association with HLA b8 & DR3 in Caucasians : 
HLA – Bw35  in Japanese. 
Family history of autoimmune disease, graves’ disease, hashimoto’s disease 
may be associated . 
PATHOLOGY 
MACROSCOPIC APPEARANCE 
           Gland is diffuse, symmetrical, smoothly enlarged with increased 
vascularity. 
MICROSCOPIC APPEARANCE 
Cells are hyperplastic with columnar epithelium , papillary projections 
& mitosis  &  with aggregates of lymphoid tissue. Colloid is reduced .  
Many follicles are empty. Some contain vacuolated colloid with the 
characteristic  scalloped pattern  adjacent to thyrocytes. 
 16
TOXIC MULTINODULAR GOITRE 
(SECONDARY THYROTOXICIOSIS) 
Toxic Nodular Goitre – Plummer’s Disease. 
Long standing MNG becomes hyper active over long period. 
Middle or elderly aged females. 
Hyperthyroidism is relatively mild .  
Not associated with extra thyroidal manifestations . 
Gland is nodular & eye signs are less common. 
In many cases it is the internodular tissue that is active & nodules are inactive. 
In some cases the nodules are active & here the toxicosis is due to autonomous 
nodules as in toxic adenoma. 
SOLITARY TOXIC NODULE 
TOXIC  ADENOMA 
              One or more nodules  trapping & organifying more iodine & secreting 
more hormone thereby producing hyperthyroidism independently of TSH 
control. 
              It is autonomous  -- not due to TRAb. TSH secretion is suppressed by 
high levels of circulating hormones. Normal thyroid tissue surrounding the 
nodule is suppressed & inactive. 
             Adenoma  is usually >3 cm in dia. 
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Pathogenesis Of Dermopathy & Ophthamopathy  Is Immune Mediated 
But Not Due To TRAb & Less Well Understood 
PATHOGENESIS OF GRAVES’ OPHTHALMOPATHY 
   It is an Autoimmune disorder—immunologically mediated, but not due 
to TRAb. Cross reaction between the thyroid antigens & ocular muscle 
antibodies. 
      Fibroblasts proliferation in orbit leading to  accumulation of  hydrophilic 
glycosaminoglycans in the retro orbital tissues which leads to increased 
interstitial fluid content . And there is also chronic inflammatory cell 
infiltration  in the retro orbital tissue. All these lead to swelling of extra ocular 
muscle & increased retro orbital pressure leading Exophthalmos & optic nerve 
compression. 
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CLINICAL MANIFESTATION 
AGE : Graves’ disease    20 – 40 yrs  
            Toxic MNG          middle or elderly  
            Toxic Adenoma   >40 yrs 
SEX : All thyroid diseases are common in females. 
           Clinical features are the same in graves’ or toxic MNG except that 
Graves’ disease is associated with more severe toxicity & with extra thyroidal 
manifestation. There may be Family history of other autoimmune diseases. 
            In Graves’ – the onset is sudden, associated with remissions & 
exacerbation & more of neurological symptoms. In toxic MNG  - the onset is 
insidious & may be  associated with cardiac failure or atrial fibrillation & more 
of cardiovascular manifestations.    
There is an increased caloric turnover & hyper metabolic state. The most 
significant symptoms are loss of weight despite increased appetite, preference 
to cold & palpitation, heat intolerance & excessive sweating. 
GASTRO INTESTINAL SYMPTOMS: 
Increased bowel motility, increased transit time 
            Diarrhoea/hyperdefecation & weight loss despite good appetite. 
Anorexia & vomitting 
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CARDIOVASCULAR SYSTEM:  
Increased heart rate , B.P ,cardiac output & blood volume. Widened 
pulse pressure (corrigan’s pulse).  
           Chest pain, dyspnea, palpitation, pedal edema, cardiomyopathy , CCF. 
Cardiac rhythm abnormalities –  
Sinus tachycardia 
           Multiple extrasystole 
           Paroxysmal atrial tachycardia & atrial fibrillation 
Persistent atrial fibrillation not  responding to digoxin.                                                       
NEUROLOGICAL                 
Nervousness,irritability,restlessness,excitability, 
Emotional liability,psychosis 
Tremor,hyper reflexia,illsustained clonus. 
MUSCULAR SYSTEM: 
                     Muscle weakness,proximal myopathy 
                     Periodic paralysis ( only noted in chinese) 
HAIR: Brittle & fine leading to  hair loss 
NAIL: Onycholysis;clubbing. 
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REPRODUCTIVE SYSTEM: 
                 Amenorrhea, oligomenorrhea Infertility, spontaneous abortion, Loss 
of libido & impotence. 
DERMATOLOGICAL: 
                Pretibial myxedema, increased sweating, pigmentation vitiligo, 
thyroid acropathy, spider naevi, palmar erythema. 
OTHER FEATURES: 
Fatigue, apathy, gynaecomastia, osteoporosis(elderly). 
NECK SWELLING: 
                Graves’ – diffuse symmetrically enlarged goiter 
                Toxic mng – multi nodularity, firm nodules 
                Toxic adenoma- single nodule palpable  
PRETIBIAL MYXEDEMA: 
                Incidence 3-5 %. Nearly always associated with true exophthalmos & 
high levels of TRAb. Infiltrative dermopathy- mucin like deposit in the skin 
causing skin  thickening. 
Symmetrical in the early stage ; characterized by shiny red plaque of 
thickened skin with coarse hair which may be cyanotic when cold. In Severe 
cases the skin of whole leg , foot & ankle are involved. Associated with 
clubbing of fingers & toes ( thyroid acropathy). 
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Treatment: rarely requires treatment. Local injection of Triamcinolone 
or betamethasone ointment under occlusive dressing may be effective. 
OCULAR MANIFESTATION 
Some degree of exophthalmos is common in all the cases. True 
exophthalmos is proptosis of eyes caused by infiltration of retrobulbar tissues 
with fluid ,round cells  &  spasm of upper eyelid. Levator palpebra superioris is 
partly innervated by sympathetic & its over activity causes lid retraction & lid 
lag. 
AMERICAN THYROID ASSOCIATION CLASSIFICATION OF EYE 
SIGNS IN GRAVES’ DISEASE 
 N   0 No Signs Or Symptoms 
 O   1 Only Signs 
 S   2 Signs & Symptoms 
 P   3 Proptosis 
 E   4 Extra Ocular Muscle Involvement 
 C   5  Corneal Involment 
 S   6 Sight Loss(Optic Nerve Damage) 
 
EYE SIGNS : 
I) Lid lag & lid retraction 
II)Signs of Exophthalmos: 
Von  Graefe’s sign  : lid lag . 
Dalrymple’s sign    :  lid retraction –upper  sclera is visible 
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Joffroy’s sign: Absence  of forehead  wrinkling when pt looks up             
Stellwag’s sign: staring look & infrequent  blinking ,widened  palpebra.    
Moebius’ sign: absence of eyeball convergence due to muscle weakness. 
III)Ophthalmoplegia: 
              Most commonly involved muscle is elevators of eye –inferior oblique 
& superior rectus. Diplopia commonly occurs at upward & outward gaze. 
IV) Chemosis: 
               Conjuctiva is edematous , congested. Edema of eyelids, conjuctival 
injection & chemosis are aggravated by compression of ophthalmic veins 
causing increased lacrimation & photophobia. 
MALIGNANT EXOPHTHALMOS: 
The above mentioned features are severe & progressive it is termed 
malignant exophthalmos. Papilledema, corneal ulceration & optic nerve 
damage & vision loss occurs. 
Examination of exophthalmos: 
                   1)Look from above for eyeball protrusion -  Naffzieger’s method. 
                   2)From front – look for scleral rim around  cornea.  
EXOPHTHALMOMETER (HERTEL): 
                   Measures the distance between lateral bony orbital margin to 
anterior surface of cornea. 
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COMPARISION BETWEEN PRIMARY & SECONDARY 
THYROTOXICOSIS 
Features Primary Thyrotoxicosis Secondary Thyrotoxicosis 
Age 20 – 40 years Middle or elderly 
Pre existing goiter  Not prominent  Long standing goiter  
Goiter Diffuse , smooth  nodular 
Exophthalmos More common  Less common  
Extra thyroidal  
manifestations 
Yes  No  
Neurological 
symptoms 
More pronounced Less  
Cardiovascular 
symptoms 
less More pronounced 
 
UNUSUAL CAUSES OF HYPERTHYROIDISM 
THYROTOXICOSIS FACTITIA: 
Hyperthyroidism induced due to  excess intake of thyroxine. It  occurs 
only if the dose exceeds the daily requirement. Doses below the daily 
requirement only suppress the normal thyroid function. RAIU Radio iodine 
uptake is low. 
Treatment : To stop the drug & treat with carbimazole or propranolol. 
JOD BASEDOWS THYROTOXICOSIS;(JOD  German word for Iodine) 
Diffuse toxic goiter is also called Basedows disease. Large doses of 
iodine given to hyperplastic endemic goiter which is iodine avid causes 
temporary hyperthyroidism.  
 24
DEQUIRVAINS’ THYROIDITIS AND  AUTOIMMUNE THYROIDITIS 
(HASHITOXICOSIS) 
During the early stage there is hyperthyroidism due to leakage of 
hormone from the gland. 
FUNCTIONING METASTATIC THYROID Ca: 
               Rarely causes hyperthyroidism. 
NEONATAL THYROTOXICOSIS: 
Babies born to hyperthyroid mother have high titres of  TSH & TRAb. 
Since both TSH & TRAb will cross the placenta. 
It gradually subsides in about 3 weeks time & Ab titre gradually comes 
down. 
POST PARTUM THYROIDITIS  
Causes hyperthyroidism in the early stage. 
TT3 THYROTOXICOSIS: 
The TT4 is normal & T3 alone is ↑. 
RAIU  is  normal.  
Commonly occurs in endemic goitre with solitary nodule. 
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INVESTIGATIONS 
ASSESMENT OF THYROID FUNCTION: 
TSH: 
      Normal level is 0.15 – 4.2 µU /ml.  
Done previously by Radioimmuno assay. Nowadays  it is done by 
Immunochemiluminometric Assay using monoclonal antibodies. 
TSH ↓  - hyperthyroidism 
TSH ↑  - hypothyroidism. 
If TSH is alterd , T3 & T4 has to be measured. 
Many consider that TSH is the most sensitive assay of thyroid function. 
TOTAL THYROXINE  (TT4) &  FREE THYROXINE (FT4) 
  TT4 : Normal level  55 – 150 nmol/L 
  FT4 : Normal level  12 – 28   pmol/L  
FT4 is ↑ in early hyperthyroidism in which the TT4 is normal. 
TOTAL T3 (TT3 )  & FREE T3 (FT3) : 
TT3 ; Normal level 1.5 – 3.5 nmol/L 
FT3 : Normal level  3  –  9    pmol/L 
FT3 is ↑ in early hyperthyroidism where the TT3 is normal. T4 is bound 
to globulin, albumin & other carrier proteins. Pregnancy, oestrogen intake & 
ocp intake all increase the carrier protein level.Increase in TBG level →  ↑ TT4 
& TT3   level leading to false positive results but FT4 & FT3 remains the same. 
So in those persons it is ideal to measure the free hormone level. 
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In some centres  total hormonal assay has been obsolete & only free 
hormone assay is done. But in some places it is still in place. Low T3 syndrome 
occurs in starvation & propranolol intake. 
ANTIBODY ASSAY: 
Antimicrosomal Ab & antithyroglobulin Ab are raised in 70% of 
hyperthyroid patients. TRAb is detected in 90% of graves’ disease. 
THYROID SCAN: ISOTOPE SCAN 
( RADIO IODINE UPTAKE STUDY) 
Thyroid scanning is carried with either radio active I 123 or Tc 99m.  I131 is 
used for radio ablation of thyroid. 
Usually after 24 hours the gland takes up 16 – 48 % of isotope and is 
detected.  
But when the uptake is  >48 %  →  hyperthyroidism. 
USG or isotope study is not useful in graves’ disease except in the case 
of post partum thyroiditis. Routine Isotope scan is inappropriate to differentiate 
between  benign & malignancy. 
Its principal value is in Toxicity with nodule or nodularity. Localization 
of overactivity of the gland will differentiate between the Toxic Adenoma & 
Toxic MNG. 
GRAVES DISEASE Diffuse ↑ in  uptake  
TOXIC MNG Internodular tissue is overactive. Remaining gland in 
suppressed 
TOXIC ADENOMA Nodule is over active. Remaining gland is suppressed 
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According to uptake it is divided into as follows: 
WARM  Uptake similar to adjacent thyroid tissue 
HOT Overactive nodule than surrounding thyroid 
COLD Nonfunctional / hypofunctional 
 
RAIU ↑ UPTAKE : 
¾ Graves’ disease 
¾ Toxic MNG 
¾ Toxic Adenoma 
RAIU ↓ UPTAKE      
¾ Thyroiditis – early phase 
¾ Iodine induced  - Jod Basedows      
¾ Hashimoto’ s disease      
ULTRASONOGRAM OF THYROID 
High frequency USG delineates the cysts & nodules. And detects 
unpalpable nodules.  
Any thyroid nodule has to subjected to FNAC &  Cysts can be 
diagnosed when aspiration is attempted as part of investigating a nodule on 
FNAC & so ultrasound is not absolutely necessary to diagnose cysts of thyroid. 
The value of USG of thyroid is decreasing nowadays. 
FINE NEEDLE ASPIRATION CYTOLOGY: 
               It is not usually required for toxic thyroid unless there is palpable 
nodule & in which carcinoma cannot be ruled.  
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            Done with 23 or 24 g needle & 10 or 20 cc syringe. In  a single prick , 
multiple passes are made inside the thyroid tissue. 
Some slides are alchohol (70%) dried & some are air dried & 
papanicolou stained. FNAC is Highly sensitive to rule out malignancy. 
X – RAY NECK AP & LATERAL VIEWS: 
Will show anteroposterior compression of trachea, lateral deviation of 
trachea, calcification of thyroid, shadow of thyroid gland & retro sternal  
goiter. 
C.T. SCAN & M.R.I. SCAN: 
Shows Retro sternal extension 
X RAY CHEST: 
Asses cardio pulmonary status , retro sternal extension, lung metastasis 
in malignancy. 
ELECTRO CARDIOGRAM & ECHO CARDIOGRAM 
To assses the cardiac status & find out any arrythmias. 
IDL SCOPY ( INDIRECT LARYNGOSCOPY): 
Assess the vocal cord status  pre operatively for clinical & medico legal 
purposes. 
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SERUM PROTEIN BOUND IODINE: 
It is cheap & can be easily assessed but lacks specificity as it measures 
the non hormonal forms of iodine in the blood. In euthyroid state , the range is 
3.5 – 8 µg per 100 ml. 
False positive results  →   pregnancy, person taking various forms 
particularly contrast media, expectorants containing iodides & oral 
contraceptive pills.      
False negative results  →  salicylates , androgens ,  hydantoin like drugs 
& in nephritic syndrome. 
FREE THYROXINE INDEX ( FTI ) 
This is calculated from the formula  
FTI = Serum T4 ( or PBI ) × T3 uptake percent.  
The normal range is from 3.5 to 8. 
This correlates closely with the level of free T4 in serum & thus accurately 
reflects the thyroid status of the person. 
T3 RESIN UPTAKE  
The patient serum is incubated with radio active T3 so that the latter 
becomes fixed to any thyroid binding protein not carrying the hormone. The 
amount fixed can be measured & thus the number of binding sites in the serum 
that are unoccupied can be measured.  
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Naturally in hyperthyroidism the number of free binding sites is low & 
in hypothyroidism this number is high. The secondary binder , where the 
unutilized radio active T3 become fixed can be resin ,or thyopac.  
The fraction of labeled T3 taken up by the resin can be compared with 
that of a standard serum & this test is called as RESIN UPTAKE RATIO.  
The normal range is 0.91 – 1.21 µg. While using thyopac method one 
may 100 percent as the mean normal value for free binding sites. In this case ≤ 
85 %  will suggest hyperthyroidism as in this case the number of free sites will 
be less.  And  a figure of  ≥ 120 %  suggests hypothyroidism as the number of 
free sites is high. 
TSH STIMULATION TEST: 
Measures the response of pituitary to I.V  administered TRH, the 
hypothalamic stimulator of TSH. TRH dose given is 400 µgm  or 1.73µgm /  
sq m. In euthyroid persons who normal pituitary function , a prompt ↑ in TSH  
which peaks at 20 – 30 minutes. In hypothyroidism , basal TSH is elevated . 
Following TRH administration , the reaction is more & TSH often reaches 100 
– 200µU/L at 30 minutes. In thyrotoxicosis, TSH response is absent when TRH 
is administerd. 
TEST FOR HYPOTHALAMO PITUITARY THYROID AXIS: 
              When TRH is given I.V in a dose of 200 µg to a normal individual , 
the level of TSH rises from basal level to 1µU/ml to a mean peak of 10 µU/ml 
at 20 min  & return to normal in 120 min.  
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              In hypothyroidism there is an exaggerated rise of an already elevated 
TSH , but hyperthyroidism there is no response of a depressed level. 
T3 SUPPRESSION TEST ( Werner ): 
           This test differentiates thyrotoxicosis from other causes of raised uptake 
e.g . iodine deficiency & autonomous nodules.       
 BASAL METABOLIC RATE ( BMR ): BMR is ↑ in thyrotoxicosis. 
S.CHOLESTEROL & CREATININE : cholesterol is ↓ in hypothyroidism & 
creatinine is ↑ in hypothyroidism. 
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MANAGEMENT 
THREE MODALITIES: 
Antithyroid Drugs 
Surgery 
Radio Iodine Ablation 
ANTITHYROID DRUGS: 
Drugs that inhibit hormone synthesis :  Propylthiouracil, Carbimazole, 
Methimazole.     
  Drugs that inhibit iodine trapping : Thiocyanate, perchlorate, nitrates 
Drugs that inhibit hormone release :  Iodides of sodium & potassium, 
iodine 
β Blockers propranolol,nadolol    
PROPYLTHIOURACIL & CARBIMAZOLE: 
Inhibit peroxidase         →        inhibit iodination &  coupling. 
Hormone synthesis is affected. Propylthiouracil  also inhibits the peripheral 
conversion of T4 → T3. Carbimazole is converted to its active metabolite 
Methimazole. In U.S.A  Propylthiouracil & Methimazole  are commonly used ; 
in U.K carbimazole is used. 
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All these drugs have no effect on the underlying disease process. 
DRUG   DOSE/DAY 
Propylthiouracil 100 – 300 mg tds 
Methimazole 10   – 30 mg tds 
Carbimazole 40  -   60 mg 
Propranolol 40 -    60 mg tds 
 
Initial Response is attained in 2 weeks. After attaining response the dose 
is reduced to maintenance dose. 
BLOCKING REPLACEMENT REGIMEN 
Usually after giving the initial high dose, the drug dose is reduced to 
maintenance dose. But in this regimen the initial high dose is continued & 
Thyroxine is supplemented  is   Blocking – replacement regimen.     
SIDE EFFECTS:  
a)Skin rashes, pyrexia, peripheral  neuritis, vasculitis, arthritis, hepatitis 
b)sore throat , fever 
c)Granulocytopenia – reversible if drug is discontinued 
d)Agranulocytosis – incidence is 1 in 250 
e)Aplastic anaemia rarely. 
When agranulocytosis occurs , it can treated with rh G-CSF. If side 
effects occurs for one drug, the therapy can be switched on to another drug as 
there is no cross reaction between the drugs. 
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ADVANTAGES: 
a)No surgery  
b)No radiation 
DISADVANTAGES: 
¾ 50 % relapse rate 
¾ toxicity & drug side effects 
¾ teratogenecity : all the drugs cross the placenta & secreted in milk 
¾ Long term follow up is necessary 
¾ Poor patient compliance – unsuitable for illiterate people. 
β BLOCKER: 
PROPRANOLOL: 
No action on the gland. Inhibits peripheral conversion of T4  → T3. 
Inhibits sympathetic activity & results in alleviation of sympathetically 
mediated symptoms like tremor, excitability, nervousness. There is rapid 
improvement of toxicity & rapid symptomatic improval. Can be used for rapid 
correction to euthyroid state before surgery. Dose is 40 mg 8th hourly. 
NADOLOL : 
Is a long acting β blocker single daily dose of 160mg/day 
IODIDES: 
Inhibits hormone release  
Lugols Iodine →  5% Iodine in 10%  Potassium Iodide solution. 
Reduces vascularity . Makes the gland firmer & easier to handle & less 
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bleeding during surgery. Usually given 10 days before surgery in a dose of 5 
drops 8th hourly mixed with milk or water. Alternatively potassium iodide 
tablets can be given  at 60 mg tds /day.  
ANTITHYROID DRUGS USED IN 3 MAIN WAYS: 
a) As a definitive form of treatment 
b) In pre op preparation for thyroidectomy 
c) In association with Radio iodine ablation 
DRUG THERAPY IS UNSUITABLE FOR THE FOLLOWING: 
           Large diffuse glands  
Toxic MNG                     
On discontinuing the drug after attaining response it  results in high rate 
of recurrence & definitive treatment in the form of Surgery or Radio iodine 
ablation is indicated in the above mentioned conditions. 
RADIOIODINE ABLATION THERAPY 
I 131 is the most commonly used drug. Therapeutic dose is higher than 
the tracer dose.  First used by Hertz & Roberts. 
Affinity of the hyper plastic thyroid gland to Iodine forms the basis for 
treatment. The Radio iodine I 131 is given as oral drink, which disintegrates 
within the gland & emits β particles which destroys the acinar cells. These β 
particles penetrate the other tissue for few mm only & so the recurrent 
laryngeal nerve , Parathyroid  &  cartilages are not affected. The   gamma 
radiation is too small to cause to any damage. 
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PROCEDURE: 
USUAL DOSE OF RADIOIODINE   I 131  
                    500 – 750 mBq   or    10 mCi    or    8500 cGy 
All patients should be made euthyroid before therapy with antithyroid 
drugs. Stop the antithyroid drug about 2 – 3 weeks before therapy to allow 
Iodine uptake of  thyroid . Radioiodine is given in the form of oral drink of I 
131. After single dose of therapy  the  response rate is 75%. Response is slower 
usually occurs in 8 – 12 weeks time If necessary & if the response does’nt 
occur in 12 weeks, the therapy can be repeated. Higher the initial dose given , 
higher is the hypothyroidism incidence & earlier is the onset of recurrence . 
Response occurs after a period of 4 – 12 weeks & during this lag period  
antithyroid  drug  is given. Before ablation a isotope scan is done is done to 
assess the size of the gland.  
SUITABLE FOR : 
¾ small or moderate sized goiter 
¾ relapse after drug or surgery 
¾ in whom surgery or drugs are contra indicated 
¾ older patients treated with radio iodine ablation . 
CONTRAINDICATIONS : 
o ABSOLUTE : Pregnancy & lactation 
o RELATIVE : Ophthalmopathy Isolated thyroid nodules or toxic  
                                       nodular goiter 
o Young age – children & adolescent 
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DISADVANTAGES: 
                Increased incidence of leukemia, thyroid malignancy & other 
malignancy. 
                Long term follow up is essential 
                Repeated doses may be required. 
COMPLICATIONS: 
¾ exacerbation of thyrotoxicosis, arrythmias & precipitation of CCF  
¾ Thyroid storm, Hypothyroidism, hyperparathyroidism 
¾ Worsening of eye signs : incidence is greater than after surgery 
¾ Fetal damage in pregnancy 
SURGERY 
Surgical Procedures For Thyroid Disorders ( 8 ) 
¾ Total Lobectomy 
¾ Subtotal Lobectomy 
¾ Isthmusectomy 
Total Thyroidectomy 2× total lobectomy  +  isthmusectomy 
Subtotal Thyroidectomy 2× subtotal lobectomy  + isthmusectomy 
Near Total Thyroidectomy Total lobectomy  +  isthmusectomy  + subtotal 
lobectomy  
Lobectomy Total lobectomy  +  isthmusectomy 
 
SUBTOTAL THYROIDECTOMY 
Leaving behind  ⅛ th of the gland. 
5 cubic cm of gland is left or 4 – 5 gm of tissue is left. 
Small remnant of gland if left on either side of the  Trachea. 
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NEAR TOTAL THYROIDECTOMY 
Leave <2 gm of thyroid .Remove one lobe completely & leave <2 gm on 
the other side(Dunhill Procedure) , so that the chance of damage to Recurrent 
laryngeal nerve is reduced in subsequent surgery if there is any recurrence. 
PRE OPERATIVE PREPARATION TO EUTHYROID STATE: 
Carbimazole: 
Usually carbimazole is given in a dose of 10 mg 8th hourly .And 
response starts usually at about 2 weeks. Euthyroid state attained in about 6 – 8 
weeks. The drug is given till the last evening before surgery. 
Propranolol: 
It is given in a dose of 40 mg 8th hourly for rapid control of symptoms. 
Response is faster & patients become euthyroid earlier. Used when surgery is 
planned earlier. 
LUGOLS IODINE 
Given in dose of 5 – 10 drops 8th hourly in milk. Usually given in the Last 10 – 
14 days before surgery is planned. 
RECOMMENDED TREATMENT: 
GRAVES DISEASE: 
Large diffuse  glands & young patients  →   Surgery 
Small, moderate sized glands  → Radioiodine  Ablation 
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The standard treatment is subtotal thyroidectomy after adequate control 
of toxicity. But following subtotal thyroidectomy it was studied that there was 
10 % recurrence rate & 70 % of patients developed hypothyroidism on 10 years 
follow up. So current consensus is to do Total Or Near Total Thyroidectomy & 
put them on thyroxine(9)  
TOXIC MNG: 
Antithyroid drug or Radio iodine therapy is less effective. Surgery Is 
The Treatment Of Choice. And in this too the original standard treatment is 
subtotal thyroidectomy. But now the current trend is  total thyroidectomy & 
thyroxine replacement.(9) 
TOXIC ADENOMA: 
Total lobectomy of the affected side is the treatment of choice. Radio 
iodine ablation can be given in elderly & unfit patients. 
RECURRENT THYROTOXICOSIS: 
Radio Iodine Ablation Therapy Is The Treatment Of Choice 
Further surgery has little place (10) 
THYROTOXICOSIS IN CHILDREN 
Radio iodine therapy is contra indicated . Following  Surgery - there is ↑ 
recurrence as the follicular cells are active. So treat them with drugs until late 
teens & failing which  surgery can be done. 
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THYROTOXICOSIS IN PREGNANCY: 
It is difficult to diagnose & also to treat. Radio iodine ablation is 
absolutely contraindicated because of fetal damage. So the therapeutic option is 
between  Surgery & drugs. Surgery has high rate of miscarriages. If it is 
planned it can be carried out in 2nd trimester. So the mode of treatment is with  
antithyroid drugs until the  2nd trimester & do surgery. Following surgery the 
patient should be replaced with thyroxine as required to avoid hypothyroidism 
as it is also equally hazardous. Both TSH & drugs cross the placental barrier& 
the baby born will be goitrous. 
Both carbimazole & propylthiouracil can used , but many favour 
propylthiouracil. Propylthiouracil crosses the placenta less than carbimazole. 
And T3 to be given to the mother along with propylthiouracil  to avoid goiter in  
neonate. Propranolol given causes sustained contraction of the uterus muscle 
tone & might result in small placenta & IUGR. And also causes Depression 
after birth, post natal bradycardia & hypoglycaemia in mother. 
TREATMENT OF EXOPHTHALMOS: 
Spasm & retraction usually disappear when hyperthyroidism is 
controlled. Recurrent hyperthyroidism & hypothyroidism will increase 
exophthalmos. Treatment is as follows: 
¾ Sleeping propped up 
¾ Wearing glasses during day 
¾ Tape the eyes during the night 
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¾ Artificial tears  to the protect against drying 
¾ Guanethedine eye drops & steroid eye drops 
¾ Massive doses of steroid (Prednisolone 60 mg/day) reduces the  
Chemosis 
¾ Orbital decompression or retro orbital radiation – may be required to 
save the eye when it is in  danger. 
¾ Orbital decompression can be done by temporal approach ( 
Rowbotham’s) or frontal approach (Naffzieger’s ). 
¾ Retro orbital Radiation by Supervoltage X rays 
¾ Lateral tarsorraphy to oppose the eyelids & prevent further ulceration    
& keratitis. 
¾  Some reports say Total thyroidectomy  alleviates the eye disease. It is 
unproved whether Total thyroidectomy is preferable to Near total or 
subtotal thyroidectomy. Total thyroidectomy should be undertaken only 
in patients with severe exophthalmos when well prepared. 
SUBTOTAL THYROIDECTOMY 
ANAESTHESIA : General Anaesthesia &  Controlled Ventilation 
POSITION : Neck Extended Position ( Rose  Position )                      
INCISION : Low Collar Transverse Skin  (or)  Crease  Incision  ( Kocher ) 
SUBPLATYSMAL FLAPS :  
                   UPPER FLAP   → upto thyroid cartilage 
                   LOWER FLAP → Upto suprasternal notch 
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Investing layer of deep cervical fascia is incised vertically in midline. 
Strap muscles are retracted or  cut if gland is large & as required. Thyroid 
gland is dissected bluntly from the adjacent sternothyroid muscle. 
¾ Middle thyroid vein : isolated , ligated & divided in between the 
ligatures. 
¾ Superior thyroid pedicle: is skeletonized , doubly ligated on patient side, 
close to the capsule with vicryl or silk. Care is taken not include or  
injure the superior laryngeal nerve. Superior laryngeal nerve is seen on 
the cricothyroid muscle in 80 % of persons. Then the gland is mobilized. 
¾ Inferior thyroid artery: is skeletonized & branches to parathyroid is 
preserved. Main artery is not ligated to avoid the parathyroid branches. 
Individual branches are then ligated with vicryl or silk close to the 
capsule. Care is taken not to include or injure the Recurrent laryngeal 
nerve. 
¾ Recurrent laryngeal nerve should be identified rather than avoiding : 
enters the larnx at the level of cricothyroid , passing under & through the 
berry’s ligament deep to the cricothyroid muscle. 
¾ Parathyroids should be preserved: upper : at the level of cricothyroid . 
lower :  found where the recurrent laryngeal nerve crosses the inferior 
thyroid artery. In 80 % the lower gland is located within 1 cm of the 
artery .    
¾ If parathyroid  or blood supply is damaged , the gland is minced & 
reimplanted into sternohyoid . 
¾ Gland is removed & cut ends of the gland sutured with the capsule with 
vicryl     
¾ Wound is closed with or without drain.  
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COMPARITIVE STUDY OF THREE TREATMENT MODALITIES 
 
POST OPERATIVE COMPLICATIONS 
TENSION HEMATOMA 
Hematoma  is deep to the deep cervical fascia. 
Usually due to slippage of  ligature of superior pedicle. Causes 
respiratory difficulty & the wound is opened to let the hematoma out even 
before shifting the pt to theatre. And the hematoma is evacuated & bleeding 
point ligated. 
CRITERIA ANTITHYROID DRUGS SURGERY 
RADIO 
IODINE 
ABLATION 
Mortality  Nil  Less than 1 % Nil  
Speed of control 8 – 12  weeks Immediate   
Response  rate 50 %  85 – 95 %  75 % 
Goiter Remains the same or 
regress 
Removed  Destroyed  
Hypothyroidism  Occasional but 
temporary 
10 % after 1 year , may 
reach 30 % later.70 % 
after 10 years 
50 % after 10 years 
Ocular changes Improved  Improvement  after 
total thyroidectomy  
(not proved).May be 
worsened. 
If severe 
exohphthalmos → 
excacerbation rate 
more than surgery 
In Patient            
( I.P) treatment 
Not usually necessary 
unless severe 
Essential before 
surgery 
Essential 
Discomfort  nil Yes  Yes 
Tetany  Nil  Transient 3 %  
Permanent 1 -2 % 
Less 
Cord palsy  Nil  Present   Nil  
Drug reactions Yes  Less as the drugs are 
discontinued before 
surgery 
Less as the drugs 
are discontinued  
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RESPIRATORY OBSTRUCTION 
Commonly due to laryngeal edema .The most important cause of 
laryngeal edema is tension hematoma. Trauma to larynx due to intubation & 
surgery are contributory. Recurrent laryngeal nerve palsy causes stridor if 
bilateral .If the respiratory difficulty is not relieved  →  re intubate the patient 
immediately . 
If intubation is not possible → emergency needle tracheostomy   
   Tracheostomy is rarely needed. 
RECURRENT LARYNGEAL NERVE INJURY 
Temporary injury → is due to traction or stretching 
Permanent injury  → is due to dividing or ligating the  nerve 
Permanent injury → incidence 1 % 
Nerve runs more obliquely on the right side than the left where it lies 
close on the tracheo oesophageal groove. Nerve is most commonly injured at 
the berry’s ligament. Where it is tethered down by the ligament Use of 
electrocautery in this area should be avoided.  
When nerve is not identified during surgery :  
 Transient paralysis is less common Permenant damage is 3 – 4 times higher. 
When nerve  is identified during surgery : 
           Transient paralysis is more common  Permenant paralysis is less 
RLN Injury →  Vocal Cord Damage   →and Cord is in Paramedian Position     
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BILATERAL NERVE DAMAGE  
→ acute respiratory distress /stridor immediately after extubation 
→ re intubate immediately                                                                                   
→Tracheostomy (if intubation is not possible) 
UNILATERAL NERVE DAMAGE 
→  Hoarseness of voice or husky voice 
→ Choking & coughing when drinking fluids (as nerve is   also sensory to  
trachea). 
If nerve damage is temporary → recovery of cord function occurs  in 6 
months to 1 year.                                                             
If recovery does not occur in 12 months opt for 
                         → Speech therapy                                                                                 
                         →Teflon injection 
Teflon injection is done lateral to the cord & it mobilizes the cord to midline & 
voice improves. 
Disease specific risk factors for RLN injury (in the order of frequency): 
 Recurrent thyroid Ca 
 Recurrent goiter 
 Large retro sternal goiter 
 Chronic lymphocytic thyroiditis 
 Graves’ disease 
 Non toxic goiter 
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EXTERNAL LARYNGEAL NERVE INJURY 
Results in difficulty in shouting or singing high note    (High note 
nerve). 
To avoid injury Superior thyroid pedicle is ligated close to the capsule. 
Ext laryngeal nerve lies on the cricothyroid in 80 %. 
THYROID INSUFFICIENCY: 
           Usually occurs within 2 years after surgery. Do hormonal assay & put 
the pt on thyroxine replacement dose. 
PARATHYROID INSUFFICIENCY 
          Usually  transient. Mostly due to ischemia to parathyroid because of 
bruising or partial interruption of blood supply. 
Manifestations 
¾ Tingling & numbness periorally & then in fingers 
¾ CHVOSTEK’S SIGN → twitching of lips when facial nerve is tapped 
infront of tragus. 
¾ Carpopedal spasm & tetany : occurs when S.Ca <8 mg/dl 
¾ TROSSEAU’S SIGN → inflate the sphygmomanometer above  systolic 
B.P   (>200 mm Hg) carpopedal spasm  
¾  Respiratory alkalosis 
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¾ Treatment : I.V Calcium gluconate as required Or 1g of Calcium every 4 
hour Usually recovers in due course. 
STITCH GRANULOMA 
Due to use of non absorbable suture material like silk. Incidence is less 
when absorbable material like vicryl is used. 
WOUND INFECTION 
HYPERTROPHIC SCAR & KELOID SCAR 
THYROID STORM ( THYROTOXIC STORM) 
Acute exacerbation of thyrotoxicosis. Occurs in thyrotoxic patient in 
whom preparation is inadequate or following some unrelated surgery. 
MANIFESTATIONS: 
Features Of Profound Thyrotoxicosis  
¾ Tachycardia  Hyperpyrexia, vomiting, diarrhea, dehydration 
¾ Disorientation, mania, coma, death 
MANAGEMENT : 
¾ I.V fluids as required, Cool the pt with ice packs, O2 
¾ Diuretics for cardiac failure & digoxin for AF, I.V. hydrocortisone 
¾ I.V. propranolol 2 mg slowly. Or 40 mg orally 6th  hourly, Carbimazole 
10 -20 mg 6th hourly, Lugols iodine 10 drops 8th hourly 
¾ Avoid aspirin  
 
 48
POST OP FOLLOW UP 
Vocal cord examination 
If the voice is good & cough is unequivocally occlusive ,it is not 
mandatory to do IDL scopy & vocal cord examination on discharging the 
patient. 
Screen for parathyroid insufficiency: 
S.Ca assay is to be done after 4 – 6 weeks  & treat if necessary. 
Thyroid hormone assay: 
After surgery, Stability of thyroid function takes some time. 
Biochemical (subclinical failure ) is not an indication for thyroxine replacement 
therapy during 1st year since majority of patients with subclincal failure will 
ultimately regain  normality. Most of the patients will develop hypothyroidism 
by 2 years. 
Recurrent thyrotoxicosis can occur at any time during life & so life long 
follow is essential. 
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MATERIALS AND METHODS 
This is a prospective study of  randomly selected patients who presented 
with hyperthyroid symptoms , toxic goiter who were diagnosed & treated at 
KILPAUK MEDICAL COLLEGE HOSPITAL, Chennai during the period of  
September  2004 – September 2006. 
Each patient’s symptoms & signs were entered in proforma with 
detailed clinical examination in relation to thyroid. All the patients were 
subjected to basic investigations like complete hemogram, blood sugar, urea, 
urine analysis, chest X-ray. 
Thyroid profile TotalT4,TotalT3,TSH done for all the patients. X – ray 
neck, E.C.G. were taken for the cases. Ultrasonogram of thyroid  &  Radio 
Isotope study was not done since the facility is not available in our hospital. 
Since Radio Iodine ablation therapy is not available in our hospital , our 
patients were treated with either antithyroid drugs or surgery. 
Surgery was the mode of treatment offered to all the patients. But out of 
50 cases , surgery was done for only 45 cases & for rest of the 5 patient surgery 
was deferred due to various reasons & those five patients were treated with 
antithyroid drugs only. 
The 45 patients who were planned for surgery were put on anti thyoird 
drugs as part of pre operative preparation to euthyroid status & to prevent 
thyrotoxic crisis. They were monitored by daily sleeping pulse chart, periodic 
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weight monitoring, & by symptomatic improval. Surgery was done after pre 
operative preparation to euthyroid state with anti thyroid drugs. 
Pre Op Preparation : Most of our patients required an average dose of  
Carbimazole 10 mg 8th hourly . And  propranolol was also given in a dose of 40 
mg 12 th hourly for patients with severe toxic symptoms. And 10 days prior to 
surgery, Lugol’s iodine 5 – 10 drops 8th hourly was given to patients. Few 
patients were given Colloidal iodine instead of Lugol’s iodine. Night sedation  
was given with Dizepam or Alprazolam. 
SURGERY in the form of → SUBTOTAL or  NEAR TOTAL or 
TOTAL THYROIDECTOMY was done. 
Post operative complications were analysed & the patients regularly 
followed up. 
The patients in whom surgery was deferred were treated with antithyroid 
drugs. 
Total T4 level 3 months after surgery ( for 45 patients )& Total T4 level  
3 months after medical therapy ( for 5 patients ) were measured & analysed. 
  All the observations were analysed & compared with standard results.  
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CASE ANALYSIS 
AGE INCIDENCE: 
Youngest age encountered was 23 years  and the oldest age is 46 years. 
The case frequency according to age group. 
   
Average Age  - 33 years 
SEX INCIDENCE: 
Thyrotoxicosis is common in females. In our series females 
predominate. The overall male  ׃  female ratio is   1׃ 9     
The sex incidence in our study is as follows: 
CASES Total cases (50) Percentage 
Male 5 10 
Female 45 90 
 
FAMILIAL INCIDENCE: 
In this study no family or hereditary incidence was noted. 
CLIMATIC VARIATIONS: 
A seasonal variation in the intensity of toxicity was suggested in studies. 
But in our study, no such climatic variation is noted. 
AGE IN RANGE (years) No. of CASES (total  50) PERCENTAGE 
20 - 30 14 28% 
31 - 40 28 56% 
41 – 50 8 16% 
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CLINICAL PRESENTATION 
Goitre was present in all the cases . And the frequency of  each type in 
our study is : 
 
Out of 50 cases,  35 patients presented with toxic MNG , 15 patients had 
Diffuse Toxic goiter & no patient had Solitary toxic nodule. 
CLINICAL FEATURES: 
All the cases studied had goiter. The incidence of various thyrotoxic symptoms 
in our study is tabulated below : 
S.No PRESENTING SYMPTOMS 
No. OF CASES 
(total – 50) PERCENTAGE 
     1 Goitre   all 100 % 
     2 Tremor 19 38% 
     3 Palpitation  35 70% 
     4 Heat intolerance 21 42% 
     5  Excitability 20 40% 
     6  Sleep disturbances 30 60% 
     7 Weight loss  32 64% 
     8 Diarrhea   32 64% 
     9 Muscle weakness 19 38% 
   10 Ophthalmopathy 11 22% 
   11 Bruit 5 10% 
   12 Menstrual abnormalities 3 6% 
 
TYPE OF GOITRE No. of Cases (50) PERCENTAGE 
Diffuse Toxic goiter (D) 15 30% 
Toxic MNG (M) 35 70% 
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Few patients had menstrual abnormalities like oligomenorrhea which 
got corrected once the patients were brought to euthyroid state. None of the 
patients included in the study had chest pain , dyspnea or any other cardiac 
symptoms or pressure symptoms like dysphagia , hoarseness of voice. 
GRADE OF TOXICITY  
The toxicity has been graded according to pulse rate as 1st degree , 2nd 
degree & 3rd degree. And the incidence in our study is as follows : 
SEVERITY OF 
TOXICITY 
PULSE RATE 
( per min) 
No. OF CASES 
(total 50) 
1st DEGREE < 90 4 
2nd DEGREE 90 - 110 16 
3rd DEGREE > 110 30 
 
TREATMENT AND FOLLOW UP 
In our series surgery was done for 45 patients. In  the rest of 5 patients 
surgery was deferred for the following reasons : 3 were not willing for surgery , 
2 were anaesthetically unfit for surgery . Those 5 patients were treated with 
antithyroid drugs.  
All the patients who were planned for surgery were put on anti thyroid 
drugs as previously stated to attain euthyroid status before surgery. 
Control Of Toxicity  After Pre-Op Preparation  
Duration for control of toxicity is analysed. Some patients with mild toxicity & 
early cases became euthyroid in 2 weeks. And  in others it ranged from 3 to 6 
weeks to control the toxicity.  For few patients it  took around 8 weeks for 
controlling toxicity. 
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SURGICAL TREATMENT : 
 Surgery done was Subtotal Thyroidectomy , Near Total Thyroidectomy, 
Total Thyroidectomy. For most of the patients Subtotal thyroidectomy was 
done. TT4 level measured in all the cases 3 months after surgery. 
SURGERY  DONE No. of CASES (45 ) 
Subtotal Thyroidectomy 33 
Near Total Thyroidectomy 8 
Total Thyroidectomy 4 
 
MEDICAL TREATMENT WITH ANTITHYROID DRUGS: 
In the 5 patient in whom surgery was deferred , antithyroid drug therapy 
was started. They were given Tab.Carbimazole 10 – 20 mg 8th hourly & Tab. 
propranolol 40 mg 12th hourly & night sedation with diazepam . TT4 level 
measured in all the cases 3 months after therapy. 
COMPLICATIONS : 
During surgery & in the post operative period the complications that 
were encountered are summarized: 
Two Patients Developed Hypoparathyroidism: It manifested as : 
¾ Tetany 
¾ Carpo pedal spasm 
¾ Chvostek’s sign positive 
¾ Trousseau’s sign positive 
¾ One patient developed symptoms on the 2nd  day , other on the 3rd day. 
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They were managed as follows: 
¾ Serum Calcium estimation 
¾ Serum phosphorus 
¾ Oral Calcium 
¾ I.V. Calcium gluconate as required. 
Two Patients Had Unilateral Recurrent Laryngeal Nerve  Palsy : 
It manifested as : 
¾ Hoarseness of voice 
¾ Coughing on taking liquid drinks 
¾ Subsequent IDL scopy showed the paralysed  vocal cord in para median 
position 
¾ They did not develop aspiration. 
¾ They were treated with I.V. steroids  (dexamethasone & hydrocortisone  
¾ They improved symptomatically subsequently. 
¾ They were  advised reassurance & did not develop any further 
complication 
One Patient Developed Stitch Granuloma; 
It presented as; 
¾ Continuous serous discharge from a sinus in the scar for about 3 months 
in the post operative period. 
¾ Wound was explored under Local Anesthesia & there was found to be 
silk suture protruding in the sinus. 
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¾ The silk was cut as low as possible & the scar excised & wound 
resutured. 
¾ Inference: Use of non absorbable suture material causes stitch 
granuloma & sinus. 
• Two patients developed wound gaping & were treated with dressing, 
resuturing etc… 
• Two patients developed subcutaneous serous collection / haematoma, 
they were treated by aspiration. 
There was no incidence of Thyroid Storm or Respiratory Distress or 
Tension Hematoma or Recurrent Thyrotoxicosis. All the patients are living 
peacefully. 
COMPLICATION RATE  
 
 
Ranges of results of 
surgery 
From Hershman ranges 
of percentage 
In our series 
percentage 
Mortality < 3.1 % Nil 
Vocal Cord Palsy 0.0 – 4.4 % 4 % 
Hypoparathyroidism 0.0 – 3.6 % 4 % 
Recurrent thyrotoxicosis 0.6 – 17.9 % Nil 
Hypothyroidism  4 – 29.7 % 20 % 
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DISCUSSION 
Most of the patients who were diagnosed to have thyrotoxicosis were in 
the age group of 31 – 40 years. Most of the patients who presented with graves’ 
disease were in the age group 20 – 30 years. Most of the cases with toxic MNG 
were in the age group of 30 – 45 years . 
In our study, incidence of thyrotoxicosis in females was high & the male 
to female ratio in our study was 1: 9.There was no familial incidence in our 
study. 
Of the types , most of the patients had Toxic MNG (35 patients) & none 
of our cases included in the study had Solitary toxic nodule.  
All the patients had goiter. The most significant clinical features were 
palpitation, weight loss , hyperdefecation, sleep disturbances, excitability & 
heat intolerance in the order of frequency. With regard to pulse rate , most of 
the cases had severe toxicity 3rd degree with pulse rate >110 / min . 
TSH, Total T4 ,Total T3 was done for all the cases . In all the cases the 
TSH was reduced & T4 & T3 was raised confirming the hyperthyroid state & 
indicating the severity of the disease. TT4 repeated for all cases 3 months after 
therapy (both surgery & drug). 
All the patients in whom surgery was planned , were given antithyroid 
drugs & taken up for surgery after adequate control of toxicity .  This prevented 
the complication of thyroid storm in the per operative & in the post operative 
period. After giving antithyroid medications , euthyroid state was attained on 
an average of  3- 4 weeks with a minimum of 2 weeks & maximum of 8 weeks  
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Most of cases underwent Subtotal thyroidectomy. All the cases were 
followed up in the post operative period until the study period .  It was noted 
that none of our patients had recurrent thyrotoxicosis & there was no mortality  
with a little morbidity . The patients who underwent total thyroidectomy were 
given thyroxine replacement in the form of Eltroxin tablets in a dose of 
0.1mg/day. The histopathology of operated specimen was studied . And there 
was no evidence of malignancy in the Histo Pathology of the operated 
specimen . 
The mean T4 level for patients treated with surgery & for patients 
treated with antithyroid drugs was analysed 3 months after therapy. The T4 
level in the patients treated with surgery was reduced significantly to normal 
level or to just below normal level in the range of 2-4 µU /ml  ( Nl level 4.5 – 
12µU/ml ). But in cases treated with antithyroid drugs the T4 level was reduced 
to an average level of  12 - 14µU/ml  which is just above the normal level 
stated above.  
Out of the 5 patients treated with anti thyroid drugs only 1 came for 
routine follow up & other 4 patients did not turn up after 3 months. And the 
significance of drug therapy in them could not be assessed properly. 
From the available data , in general it can be stated that surgery is the 
appropriate form of treatment that can be safely offered to patients with 
thyrotoxicosis in our set up since most of the patients do not come for routine 
& regular follow up .  
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CONCLUSION   
In this study a comprehensive account of history , anatomy, physiology 
with a detailed account of the clinicopathological aspects, presentations & 
various modalities of treatment of thyrotoxicosis have been dealt with. 50 cases 
of thyrotoxicosis have been dealt with. 
From the evidence, it is clear that after adequate control of toxicity with 
anti thyroid drugs, surgery is the modality of treatment that can be safely 
offered to patients with thyrotoxicosis in our set up. 
This present study confirms the observation made by the reputed authors 
& emphasizes the importance of perfect & sufficient pre operative preparation, 
meticulous surgical technique, detailed knowledge about anatomy of thyroid , 
parathyroid  & associated nerves assures complete remission with negligible 
morbidity & nil mortality. 
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THYROTOXICOSIS  CASE  PROFORMA 
 Name :                                                         Age :                  Sex  
 Address:                                                                              Occupation      
 I.P no.    :                                                    
 D.O.A   :              D.O.S    :            D.O.D   : 
COMPLAINTS     
                                                                                  
H/O PRESENT ILLNESS 
SYMPTOMS   
Swelling  
                    Mode of onset                     
                    rate of growth 
pain 
Increased  appetite & weight loss heat intolerance & preference to cold, 
excessive sweating,   excitablity, irritablity, restlessness, Insomnia, tremor of 
hands,  palpitation,  muscle weakness,  visual disturbance,diplopia, protrusion 
of eyes,  Chest pain, dyspnea, dysphagia,hoarseness of voice 
 H/O PAST ILLNESS 
                  HT, TB, DM 
PERSONAL  HISTORY 
                  Smoking ,Alchohol 
                  Intake of brassica vegetables  
Family history: 
Menstrual history: 
Obstetric  history: 
Treatment history;*drug intake 
                              *irradiation 
                              *surgery 
GENERAL EXAMINATION: 
 Built      Nutrition    anaemia      dyspnea      jaundice cyanosis 
Generalized lymphadenopathy 
Tremor of hands   & tongue                                
Leg edema(pretibial myxedema) 
  
Eye signs:  Lid retraction   &  Lid lag 
Exopthalmos  –  Von graefe’s sign,  Joffroy’s sign, Stellwag’s sign, Moebius 
sign, Dalrympte’s sign,  Ophthalmoplegia, Chemosis 
PR;  Sleeping PR RR B.P Temp CVS   RS   ABD           CNS                    
  LOCAL EXAMINATION OF NECK 
 INSPECTION 
 Swelling 
 Site 
 Size 
 Shape 
 Extent 
 Borders 
 Movement with deglutition 
 Movement with protrusion  of tongue 
 Skin over the swelling 
 Surface 
 On sternomastoid contraction - 
 Trachea position 
PALPATION 
 Warmth  
 Tenderness 
 Site ,size ,shape,extent 
 Borders 
 Skin over the swelling 
 Surface 
 Consistency 
 Mobility 
 Trachea position 
 Carotid pulsation 
 Kocher’s test 
 Pemberton’s sign 
 PERCUSSION Over manubrium                   
 AUSCULTATION: Bruit                           
  
 LYMPH NODES 
 SKELETAL SYSTEM & SPINE 
 DIAGNOSIS 
 INVESTIGATIONS 
 Hb                Tc                             Dc                                       
 ESR 
 Bl. Sugar                                                 Urine R/E  
 E.C.G   ECHOCARDIOGRAM  
 X – RAY CHEST                                    X– RAY NECK 
THYROID FUNCTION TEST 
                                                                            Nl value 
                   TSH, TT4,  TT3,  FT4,  FT3 
ANTIBODY, USG THYROID, THYROID SCAN,  IDL,  FNAC 
TREATMENT 
MEDICAL   
          Drug          Dose        Duration                Toxicity 
 1) 
 2) 
 3) 
         Treatment for drug toxicity 
         Control of toxicity attained after ………weeks 
SURGERY: …………………………………………… 
 Post op complications: 
            Type                                                                 Treatment   
1)………………………… 
 2)…………………………. 
 3)…………………………. 
 PROPRANALOL continued in the post operative period for 7 days 
 H.P.E 
 FOLLOW UP 
 
 
 
  
 
 
 
 
RECURRENT LARYNGEAL NERVE – RELATION 
WITH TRACHEO ESOPHAGEAL GROOVE & 
INFERIOR THYROID ARTERY 
 
 
 
 
  
 
 
 
RLN IN RELATION TO INFERIOR THYROID ARTERY & 
PARATHYROIDS 
 
 
 
 
DEVELOPMENT OF THYROID 
 
  
 
THYROID HORMONE SYNTHESIS 
 
 
 
 
 
HYPOTHALAMO PITUITARY THYROID AXISp 
  
AGE INCIDENCE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
SEX INCIDENCE 
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INCIDENCE OF CLINICAL FEATURES 
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NORMAL THYROID HISTOLOGY 
 
 
 
 
MICROSCOPIC PICTURE IN 
HYPERTHYROIDISM 
 
  
 
A CASE OF TOXIC MNG 
 
 
 
A CASE OF MNG 
  
 
POSITION DURING SURGERY 
 
 
 
INCISION AND RAISING THE FLAPS 
 
 
 
  
 
AFTER SUBTOTAL 
THYROIDECTOMY 
 
 
 
RECURRENT LARYNGEAL NERVE 
 
  
 
WOUND IN THE POST OP PERIOD 
 
 
 
 
    CASE OF TOXIC GOITRE 
WITH EXOPHTHALMOS 
 
  
 
DEMONSTRATION OF 
CHVOSTEK’S SIGN 
 
 
 
DEMONSTRATION OF 
TROUSSEAU’S SIGN 
 
